|
Claris Lifesciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
-
|
P/BV
|
-
|
Book Value (Rs.)
|
-
|
|
52 Week High/Low (Rs.)
|
-
|
FV/ML
|
-
|
P/E(X)
|
-
|
|
Bookclosure
|
-
|
EPS (Rs.)
|
-
|
Div Yield (%)
|
-
|
|
(Rs. in Crs.)
| Months | 15 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 144.47 | 107.49 | 135.78 | 151.46 |
| | | | | |
| Net CashFlow From Operating Activities | -44.26 | 143.38 | 334.18 | -18.93 |
| Net Cash Used In Investing Activities | -120.02 | 197.01 | -436.61 | -221.22 |
| Net Cash Used From Financing Activities | 152.21 | -342.88 | 58.27 | -24.20 |
| | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -12.07 | -2.49 | -44.16 | -264.35 |
| Cash And Cash Equivalents Begin of Year | 73.79 | 76.28 | 120.44 | 384.79 |
| Cash And Cash Equivalents End Of Year | 61.73 | 73.79 | 76.28 | 120.44 |